The purpose of this study is to demonstrate that treatment with a 6-monthly injection of
hormone therapy is as good and as well tolerated as the standard 3-monthly hormone therapy
injections available for treating prostate cancer. The study will also aim to answer whether
both doctors and patients would prefer treatment with a 6-monthly injection rather than
injections every 3 months.